ZEPOSIA Trademark

Trademark Overview

On Monday, November 18, 2019, a trademark application was filed for ZEPOSIA with the United States Patent and Trademark Office. The USPTO has given the ZEPOSIA trademark a serial number of 88696906. The federal status of this trademark filing is REGISTERED as of Tuesday, December 7, 2021. This trademark is owned by Celgene Corporation. The ZEPOSIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of autoimmune disease, multiple sclerosis and ulcerative colitis
zeposia

General Information

Serial Number88696906
Word MarkZEPOSIA
Filing DateMonday, November 18, 2019
Status700 - REGISTERED
Status DateTuesday, December 7, 2021
Registration Number6584117
Registration DateTuesday, December 7, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements

Description of MarkThe mark consists of the word "ZEPOSIA" in dark blue with a triangle design in gray, blue and red to the left.
Goods and ServicesPharmaceutical preparations for use in the treatment of autoimmune disease, multiple sclerosis and ulcerative colitis
Indication of Colors claimedThe color(s) blue, gray, and red is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 6, 2019
Primary Code005
First Use Anywhere DateMonday, June 1, 2020
First Use In Commerce DateMonday, June 1, 2020

Trademark Owner History

Party NameRECEPTOS LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressPrinceton, NJ 08543
Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Thursday, November 21, 2019NEW APPLICATION ENTERED
Friday, December 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 7, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 19, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 30, 2019ASSIGNED TO EXAMINER
Monday, January 6, 2020SUSPENSION LETTER WRITTEN
Monday, January 6, 2020LETTER OF SUSPENSION E-MAILED
Monday, January 6, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 19, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 19, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 26, 2020SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, August 5, 2020ASSIGNED TO LIE
Monday, September 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 27, 2020SUSPENSION INQUIRY WRITTEN
Thursday, August 27, 2020INQUIRY TO SUSPENSION E-MAILED
Thursday, August 27, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 2, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, September 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 17, 2020NON-FINAL ACTION E-MAILED
Thursday, September 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 17, 2020NON-FINAL ACTION WRITTEN
Thursday, September 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 25, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, September 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 1, 2020ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 14, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 14, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 14, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 14, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 13, 2021USE AMENDMENT FILED
Wednesday, October 13, 2021TEAS STATEMENT OF USE RECEIVED
Friday, October 29, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 29, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 2, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 3, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 7, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, March 13, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

zeposia sclerosis ulcerative colitis multiple disease preparations treatment autoimmune pharmaceutical